Mitochondrial-nuclear crosstalk: A central axis in Alzheimer’s disease
Ageing Research Reviews · 2026-07 · 119 · 103150
DOI: 10.1016/j.arr.2026.103150 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-07. Verfasst von Kunal Samantaray und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston, Salem, NC 27157, …. Hauptthemen laut MEDLINE: Alzheimer Disease, Mitochondria, Cell Nucleus, Brain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Alzheimer's Association, NIA NIH HHS, NIDDK NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a progressive neurodegenerative disorder traditionally defined by amyloid-β plaques and tau tangles. However, growing evidence indicates that deeper disruptions in cellular homeostasis contribute to disease onset and progression. Among these, impaired communication between mitochondria and the nucleus has emerged as a central yet underrecognized pathological feature. Mitochondrial-nuclear (mito-nuclear) crosstalk regulates energy metabolism, stress responses, and survival pathways, making it a critical determinant of brain aging and AD vulnerability. Despite its importance, the mechanisms coordinating this bidirectional dialogue and how their breakdown drives neurodegeneration remain poorly understood. This review highlights the major molecular pathways governing mito-nuclear signaling under physiological conditions, including anterograde pathways (PGC-1α/NRF1/2/TFAM) and retrograde stress responses (ROS, calcium, mitokines, and the mitochondrial unfolded protein response). In AD, these pathways are disrupted, leading to mitochondrial dysfunction, impaired proteostasis, metabolic reprogramming, and inflammation. Emerging evidence suggests that mito‑nuclear signaling deficits arise early often preceding classical Aβ and tau pathology positioning them as potential upstream drivers of disease. We further discuss therapeutic strategies aimed at restoring mito‑nuclear communication, including NAD⁺ supplementation, mitophagy enhancers, mitochondria‑targeted antioxidants, and gene‑based approaches, emphasizing the importance of combinatorial and cell‑type‑specific interventions. Finally, we highlight how single‑cell and spatial transcriptomic technologies are enabling high‑resolution mapping of mito‑nuclear dynamics in aging and AD. Together, these insights underscore mito‑nuclear signaling as a promising but underexplored therapeutic target for modifying AD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Section of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston, Salem, NC 27157, United States; Sticht Center for Healthy Aging and Alzheimer's Prevent…
- Department of Cardiovascular Medicine, Wake Forest University School of Medicine, Winston, Salem, NC 27157, United States; Cardiovascular Sciences Center, Wake Forest University School of Medicine, Winston, Salem, NC 27…
- Department of Cardiovascular Medicine, Wake Forest University School of Medicine, Winston, Salem, NC 27157, United States; Sticht Center for Healthy Aging and Alzheimer's Prevention, Wake Forest University School of Med…
Förderung
- Alzheimer's Association
- NIA NIH HHS
- NIDDK NIH HHS
- American Heart Association-American Stroke Association
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute on Aging
- National Institutes of Health
- Alzheimer's Association
Zitieren
APA
Samantaray, K., Sinha, A., Tomar, D., & Jadiya, P. (2026). Mitochondrial-nuclear crosstalk: A central axis in Alzheimer’s disease. Ageing Research Reviews, 119, 103150. https://doi.org/10.1016/j.arr.2026.103150
Vancouver
Samantaray K, Sinha A, Tomar D, Jadiya P. Mitochondrial-nuclear crosstalk: A central axis in Alzheimer’s disease. Ageing Research Reviews. 2026;119:103150. doi:10.1016/j.arr.2026.103150
BibTeX
@article{Samantaray2026,
author = {Samantaray, Kunal and Sinha, Anupriya and Tomar, Dhanendra and Jadiya, Pooja},
title = {Mitochondrial-nuclear crosstalk: A central axis in Alzheimer’s disease},
journal = {Ageing Research Reviews},
year = {2026},
volume = {119},
pages = {103150},
doi = {10.1016/j.arr.2026.103150}
}
EUVIMED